PTC Therapeutics | PTCT - 资产



金融业
股票价格
USD 63.49
资产
USD 3.21B
现金及等价物
USD 508.89M
销售成本
USD 19.92M
流动资产
USD 2.54B
流动负债
USD 776.08M
债务
USD 2.84B
EBIT
USD 146.03M
EBITDA
USD 161.9M
员工
939
EPS每股收益
USD -0.62
股本和储备
USD -191.21M
销售毛利
USD 321.55M
债务利息支出
USD 3.21B
贷款资金
USD 536.27M
市值
USD 4.86B
净收入
USD 83.5M
营业费用
USD 211.54M
营业利润
USD 148.98M
普通股股本
USD 83.33M
PE价格收益
8.76
税前利润
USD -41.09M
销售收入
USD 357.8M
销售和管理费用
USD 80.63M
股票
USD 109.33M
贸易债权人
USD 41.59M
应收帐款人
USD 239.04M


资产 更改 日
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amgen USD 96.05B 409M 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Cytokinetics USD 1.82B 99.77M 2026-09
Daiichi Sankyo JPY 4.26T 144.08B 2026-09
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Gilead Sciences USD 51.41B 2.05B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
Ironwood Pharmaceuticals USD 290.59M 5.46M 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
TG Therapeutics USD 1.59B 47.38M 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09
Xencor USD 770.5M 45.54M 2026-09